MEDAXONUM

This brand name is authorized in Cyprus, Hong Kong, Malta

Active ingredients

The drug MEDAXONUM contains one active pharmaceutical ingredient (API):

1 Ceftriaxone UNII 75J73V1629 - CEFTRIAXONE

Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death. Read about Ceftriaxone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MEDAXONUM Powder for solution for injection/infusion	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 49794, 49795, 56644
Country: MT	Medicines Authority	Identifier(s): MA032/03001, MA032/03002, MA032/03003